Healthcare provider profile · identity verified

Jay Randal Sloop, M.D.

Family Practice · PARADISE, CA · NPI 1477638807

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	666	187
Atorvastatin Calcium	Atorvastatin Calcium	621	194
Amlodipine Besylate	Amlodipine Besylate	417	123
Losartan Potassium	Losartan Potassium	362	118
Pantoprazole Sodium	Pantoprazole Sodium	294	106
Lisinopril	Lisinopril	265	83
Gabapentin	Gabapentin	250	83
Rosuvastatin Calcium	Rosuvastatin Calcium	229	71
Pravastatin Sodium	Pravastatin Sodium	226	73
Tamsulosin Hcl	Tamsulosin Hcl	226	70
Alendronate Sodium	Alendronate Sodium	222	74
Furosemide	Furosemide	209	73
Hydrochlorothiazide	Hydrochlorothiazide	176	66
Metformin Hcl Er	Metformin Hcl	170	54
Trazodone Hcl	Trazodone Hcl	168	55
Omeprazole	Omeprazole	162	49
Tramadol Hcl	Tramadol Hcl	157	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	154	45
Simvastatin	Simvastatin	154	50
Potassium Chloride	Potassium Chloride	141	59
Glipizide Er	Glipizide	139	43
Metoprolol Succinate	Metoprolol Succinate	136	44
Zolpidem Tartrate	Zolpidem Tartrate	135	25
Azithromycin	Azithromycin	128	99
Eliquis	Apixaban	125	35
Sertraline Hcl	Sertraline Hcl	124	41
Allopurinol	Allopurinol	110	30
Quetiapine Fumarate	Quetiapine Fumarate	105	33
Metoprolol Tartrate	Metoprolol Tartrate	99	33
Ozempic	Semaglutide	97	17
Donepezil Hcl	Donepezil Hcl	95	29
Lorazepam	Lorazepam	92	23
Escitalopram Oxalate	Escitalopram Oxalate	89	34
Metformin Hcl	Metformin Hcl	88	27
Meloxicam	Meloxicam	87	41
Ropinirole Hcl	Ropinirole Hcl	87	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	25
Prednisone	Prednisone	81	53
Spironolactone	Spironolactone	81	27
Famotidine	Famotidine	79	27
Synthroid	Levothyroxine Sodium	79	26
Clopidogrel	Clopidogrel Bisulfate	72	27
Alprazolam	Alprazolam	68	31
Carvedilol	Carvedilol	68	17
Finasteride	Finasteride	66	24
Jardiance	Empagliflozin	64	21
Duloxetine Hcl	Duloxetine Hcl	62	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	15
Celecoxib	Celecoxib	61	22
Fluconazole	Fluconazole	59	37
Bupropion Xl	Bupropion Hcl	55	19
Carbidopa-Levodopa	Carbidopa/Levodopa	55	16
Clonazepam	Clonazepam	53	14
Propranolol Hcl	Propranolol Hcl	53	18
Sumatriptan Succinate	Sumatriptan Succinate	53	13
Tizanidine Hcl	Tizanidine Hcl	53	25
Fluoxetine Hcl	Fluoxetine Hcl	52	19
Albuterol Sulfate Hfa	Albuterol Sulfate	51	33
Citalopram Hbr	Citalopram Hydrobromide	51	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	45
Fluticasone Propionate	Fluticasone Propionate	49	24
Ondansetron Hcl	Ondansetron Hcl	49	18
Venlafaxine Hcl Er	Venlafaxine Hcl	48	14
Atenolol	Atenolol	46	13
Benazepril Hcl	Benazepril Hcl	46	15
Methenamine Hippurate	Methenamine Hippurate	45	16
Valacyclovir	Valacyclovir Hcl	45	26
Humalog Kwikpen U-100	Insulin Lispro	42	suppressed
Mirtazapine	Mirtazapine	42	18
Montelukast Sodium	Montelukast Sodium	38	14
Labetalol Hcl	Labetalol Hcl	37	suppressed
Pregabalin	Pregabalin	37	13
Myrbetriq	Mirabegron	36	11
Cephalexin	Cephalexin	35	29
Ezetimibe	Ezetimibe	35	13
Triamcinolone Acetonide	Triamcinolone Acetonide	35	17
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	13
Novolog Flexpen	Insulin Aspart	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Valsartan	Valsartan	31	suppressed
Levofloxacin	Levofloxacin	30	24
Irbesartan	Irbesartan	29	11
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	24
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ketoconazole	Ketoconazole	27	17
Lovastatin	Lovastatin	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Mounjaro	Tirzepatide	25	suppressed
Terbinafine Hcl	Terbinafine Hcl	25	13
Imiquimod	Imiquimod	24	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Ibuprofen	Ibuprofen	23	11
Ondansetron Odt	Ondansetron	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Raloxifene Hcl	Raloxifene Hcl	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Temazepam	Temazepam	21	suppressed
Digoxin	Digoxin	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Nystatin	Nystatin	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Mupirocin	Mupirocin	18	16
Cholestyramine Light	Cholestyramine	17	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Amoxicillin	Amoxicillin	14	14
Armour Thyroid	Thyroid,pork	14	suppressed
Baclofen	Baclofen	14	suppressed
Ofloxacin	Ofloxacin	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ramipril	Ramipril	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Topiramate	Topiramate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levoxyl	Levothyroxine Sodium	12	suppressed
Modafinil	Modafinil	12	suppressed
Naproxen	Naproxen	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Fluorouracil	Fluorouracil	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Metolazone	Metolazone	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error